Search

Your search keyword '"Escudero, Pilar"' showing total 273 results

Search Constraints

Start Over You searched for: Author "Escudero, Pilar" Remove constraint Author: "Escudero, Pilar"
273 results on '"Escudero, Pilar"'

Search Results

1. Evaluating AI Methods for Pulse Oximetry: Performance, Clinical Accuracy, and Comprehensive Bias Analysis.

4. Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials

7. Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients

9. First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)

10. Are Activity Wrist-Worn Devices Accurate for Determining Heart Rate during Intense Exercise?

21. Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinoma

24. Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results

25. INDIRECT DETECTION OF STEROIDS ABUSE IN SPORTS BASED ON ANDROGENIC ACTIVITY MEASUREMENT BY AR CALUX® BIOASSAY REFERENCES [1] Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays. Study design and Subjets

26. Position statement of the Royal Spanish Football Federation for the resumption of football activities after the COVID-19 pandemic

27. Bioanalytical Detection of Steroid Abuse in Sports Based on the Androgenic Activity Measurement

29. Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5′fluoruracil-based adjuvant chemotherapy

31. Position statement of the Royal Spanish Football Federation for the resumption of football activities after the COVID-19 pandemic (June 2020)

32. First-line biological agents plus chemotherapy in elderly patients with metastatic colorectal cancer: A retrospective pooled analysis.

34. Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer

35. Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study

36. RESULTS OF A PILOT TRIAL OF IMMUNOTHERAPY WITH DENDRITIC CELLS PULSED WITH AUTOLOGOUS TUMOR LYSATES IN PATIENTS WITH ADVANCED CANCER

37. Deletions Affecting Codons 557-558 of the c-KIT Gene Indicate a Poor Prognosis in Patients With Completely Resected Gastrointestinal Stromal Tumors: A Study by the Spanish Group for Sarcoma Research (GEIS)

39. Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study

44. Prognostic value of serum S-100B protein in melanoma

45. Immune abnormalities in patients with melanoma

49. X Encuentro Mundial de las Familias: “El Amor Familiar: Vocación y Camino de Santidad”.

50. Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti–Epidermal Growth Factor Receptor Therapy

Catalog

Books, media, physical & digital resources